Your browser doesn't support javascript.
loading
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas.
Roswarski, Joseph; Roschewski, Mark; Melani, Christopher; Pittaluga, Stefania; Lucas, Andrea; Steinberg, Seth M; Jaffe, Elaine S; Waldmann, Thomas A; Wilson, Wyndham H.
Afiliação
  • Roswarski J; a Center for Cancer Research, National Cancer Institute , Bethesda , MD , USA.
  • Roschewski M; b Tripler Army Medical Center , Honolulu , HI , USA.
  • Melani C; a Center for Cancer Research, National Cancer Institute , Bethesda , MD , USA.
  • Pittaluga S; a Center for Cancer Research, National Cancer Institute , Bethesda , MD , USA.
  • Lucas A; c Laboratory of Pathology , National Cancer Institute , Bethesda , MD , USA.
  • Steinberg SM; a Center for Cancer Research, National Cancer Institute , Bethesda , MD , USA.
  • Jaffe ES; a Center for Cancer Research, National Cancer Institute , Bethesda , MD , USA.
  • Waldmann TA; c Laboratory of Pathology , National Cancer Institute , Bethesda , MD , USA.
  • Wilson WH; a Center for Cancer Research, National Cancer Institute , Bethesda , MD , USA.
Leuk Lymphoma ; 60(8): 2062-2066, 2019 08.
Article em En | MEDLINE | ID: mdl-30626252
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Extranodal de Células T-NK / Alemtuzumab Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Extranodal de Células T-NK / Alemtuzumab Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article